Annual Reports

 
Quarterly Reports

 
8-K

 
Other

NovaMed 8-K 2009

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic
Unassociated Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported):  July 30, 2009


                      NovaMed, Inc.      
(Exact Name of Registrant as Specified in Charter)


Delaware
0-26625
36-4116193
(State or Other Jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
     
     
980 North Michigan Avenue, Suite 1620, Chicago, Illinois
60611
(Address of Principal Executive Offices)
(Zip Code)

Registrant’s telephone number, including area code (312) 664-4100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o           Written communications pursuant to Rule 425 under the Securities Act

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 
 

 


Section 2 – Financial Information

Item 2.02  Results of Operations and Financial Condition.
 
On July 30, 2009, NovaMed, Inc. issued a press release announcing its results of operations for the period ended June 30, 2009.  A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
 
The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
Section 9 – Financial Statements and Exhibits

Item 9.01  Financial Statements and Exhibits

(c)           Exhibits

Exhibit No.
Exhibit
   
99.1
Press release of NovaMed, Inc. dated July 30, 2009




 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
NovaMed, Inc.
     
     
Dated:  July 30, 2009
By:
    /s/ Scott T. Macomber
   
Scott T. Macomber
   
Executive Vice President and Chief Financial Officer







 
 

 

EXHIBIT INDEX

Exhibit No.
Exhibit
   
99.1
Press release of NovaMed, Inc. dated July 30, 2009




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki